Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Part of paid clinical trials in Ventura, California.

Sponsor
ProgenaBiome
Study ID
NCT06647277
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Fecal Microbiota Transplant — COMBINATION_PRODUCT
    Fecal Microbiota Transplant

Study Details

FMT may significantly improve quality of life and Parkinson Disease (PD) symptom severity measurements. We hypothesize that gut microbial dysbiosis is a major contributing factor in Parkinson's disease.

Key Dates

Start date
Jul 31, 2026
Status verified
Jun 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: PD patients
    This is an open-label clinical trial to evaluate the Safety of fecal microbiota transplant following a 10 day treatment with Vancomycin in adult subjects with Parkinson's disease.

Primary Outcome Measure

Parkinson's disease symptoms [ Time Frame: 6.5 months for each subject ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Sabine HazanVenturaCalifornia93003-

Find similar trials in Ventura, CA

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Sabine Hazan· Ventura, CA

Related Studies